The effects of exposure at constant (1 h) or exponentially decreasing concentrations of quinupristin/dalfopristin on biofilms of Gram-positive bacteria

被引:11
作者
Gander, S [1 ]
Finch, R [1 ]
机构
[1] Univ Nottingham, City Hosp, Sch Clin Lab Sci, Div Microbiol & Infect Dis, Nottingham NG5 1PB, England
关键词
D O I
10.1093/jac/46.1.61
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Using a biofilm model, infections by Staphylococcus aureus, coagulase-negative staphylococci and enterococci were stud led. The biofilms were exposed to quinupristin/dalfopristin and five comparator antibiotics: ciprofloxacin, vancomycin, teicoplanin, flucloxacillin and erythromycin. Two methods of exposure to the drugs were used: constant for 1 h, and exponentially decreasing, with the rate of dilution being matched to the half-lives of the antibiotics. The effects of antibiotic exposure were monitored by performing viable counts on the cells eluted from the biofilms. The results are presented as the inhibitory or bactericidal effect (the reduction in numbers of bacteria eluted from the biofilms) and recovery times (the time taken for the number of cells eluted from the biofilms to return to the number eluted before the drug exposure). Quinupristin/dalfopristin was the most effective of the six antibiotics studied, especially against enterococci. However, there were no significant differences in the effects, inhibitory/bactericidal or recovery times, produced by the two methods of exposure. The two glycopeptides showed a surprising lack of activity.
引用
收藏
页码:61 / 67
页数:7
相关论文
共 29 条
[1]   THE IN-VITRO ACTIVITY OF A NEW SEMISYNTHETIC STREPTOGRAMIN COMPOUND, RP-59500, AGAINST STAPHYLOCOCCI AND RESPIRATORY PATHOGENS [J].
ANDREWS, JM ;
WISE, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (04) :849-853
[2]   Emerging resistance to antimicrobial agents in gram-positive bacteria - Pneumococci [J].
Appelbaum, PC .
DRUGS, 1996, 51 :1-5
[3]   Gram-positive resistance: challenge for the development of new antibiotics [J].
Baquero, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 :1-6
[4]   In-vitro bactericidal activity of quinupristin/dalfopristin against adherent Staphylococcus aureus [J].
Berthaud, N ;
Desnottes, JF .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 :99-102
[5]   Time-kill kinetics of quinupristin/dalfopristin on Staphylococcus aureus with and without a raised MBC evaluated by two methods [J].
Boswell, FJ ;
Sunderland, J ;
Andrews, JM ;
Wise, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 :29-32
[6]   In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin [J].
Bouanchaud, DH .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 :15-21
[7]   AMANTADINE PROPHYLAXIS FOR HEALTH-CARE WORKERS - UNANSWERED QUESTIONS [J].
COX, RA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (01) :1-3
[8]  
Craig W.A., 1991, Antibiotics in Laboratory Medicine, V3rd ed., P403
[9]   SIGNIFICANCE OF BIOFILM-ADHERENT BACTERIAL MICROCOLONIES ON TENCKHOFF CATHETERS OF CAPD PATIENTS [J].
DASGUPTA, MK ;
COSTERTON, JW .
BLOOD PURIFICATION, 1989, 7 (2-3) :144-155
[10]   INFECTIONS ASSOCIATED WITH INDWELLING DEVICES - CONCEPTS OF PATHOGENESIS - INFECTIONS ASSOCIATED WITH INTRAVASCULAR DEVICES [J].
DICKINSON, GM ;
BISNO, AL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (05) :597-601